ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Voyager Therapeutics Inc

Voyager Therapeutics Inc (VYGR)

3,46
0,14
(4,22%)
Fermé 12 Juin 10:00PM
3,43
-0,03
(-0,87%)
Après les heures de négociation: 1:56AM

Voyager Therapeutics Inc (VYGR) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
3,43
( 3,31% )
Prix Achat
3,33
Prix Vente
3,49
Volume échangé
650 626
3,26 Fourchette du Jour 3,49
2,83 Plage de 52 semaines 5,55
Cap du marché
Clôture Veille
3,32
Ouverture
3,32
Dernière Transaction
18
@
3.41
Dernière heure de transaction
Volume financier
US$ 2 224 770
VWAP
3,4194
Volume moyen (3 m)
US$ 680 181
Actions en circulation
60 421 287
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-1,7
Bénéfice par action (BPA)
-1,98
Chiffre d'affairess (LTM)
36,49M
Bénéfice net (LTM)
-116,64M

À propos de Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides re... Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease. The company also provides research program for the treatment of Huntington’s disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Lexington, United States
Fondé
2026
Voyager Therapeutics Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker VYGR. Le dernier cours de clôture d'Voyager Therapeutics était de US$3,32. Au cours de la dernière année, les actions de Voyager Therapeutics ont été négociées dans une fourchette de prix de US$ 2,83 à US$ 5,55.

Voyager Therapeutics compte actuellement 60 421 287 actions en circulation. La capitalisation boursière d'Voyager Therapeutics est de US$207,25 million. Voyager Therapeutics a un ratio cours/bénéfice (ratio PE) de -1.70.

VYGR Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.17-4.722222222223.63.763.2825106673.41931602CS
4-0.87-20.23255813954.34.463.2825947823.6579674CS
12-0.33-8.776595744683.764.463.2825426903.84889956CS
26-1-22.57336343124.435.4783.266131084.01253249CS
52-0.11-3.107344632773.545.552.836482703.96150267CS
156-9.67-73.816793893113.114.072.6455444836.09300451CS
260-1.43-29.42386831284.8614.33982.467511385.49057999CS

VYGR - Frequently Asked Questions (FAQ)

What is the current Voyager Therapeutics Inc share price?
The current share price of Voyager Therapeutics Inc is US$ 3,43
How many Voyager Therapeutics Inc shares are in issue?
Voyager Therapeutics Inc has 60 421 287 shares in issue
What is the market cap of Voyager Therapeutics Inc?
The market capitalisation of Voyager Therapeutics Inc is USD 207,25M
What is the 1 year trading range for Voyager Therapeutics Inc share price?
Voyager Therapeutics Inc has traded in the range of US$ 2,83 to US$ 5,55 during the past year
What is the PE ratio of Voyager Therapeutics Inc?
The price to earnings ratio of Voyager Therapeutics Inc is -1,7
What is the cash to sales ratio of Voyager Therapeutics Inc?
The cash to sales ratio of Voyager Therapeutics Inc is 5,58
What is the registered address of Voyager Therapeutics Inc?
The registered address for Voyager Therapeutics Inc is 75 Hayden Avenue, Lexington, Massachusetts, 02421
What is the Voyager Therapeutics Inc website address?
The website address for Voyager Therapeutics Inc is www.voyagertherapeutics.com
Which industry sector does Voyager Therapeutics Inc operate in?
Voyager Therapeutics Inc operates in the Biotechnology & Life Sciences sector

VYGR Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion